John P. Longenecker
Founder presso Jpl Biotech
Profilo
John P.
Longenecker founded Jpl Biotech, where he worked as President.
Dr. Longenecker also currently works at HBM Healthcare Investments (Cayman) Ltd., as Director.
Dr. Longenecker also formerly worked at Favrille, Inc., as President, Chief Executive Officer & Director from 2002 to 2009, Aileron Therapeutics, Inc., as President & Chief Executive Officer in 2018, VitreoRetinal Technologies, Inc., as President, Chief Executive Officer & Director from 2009 to 2010, HemaQuest Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2010 to 2014, MMRGlobal, Inc., as President & Chief Executive Officer, Scios, Inc., as Vice President & Development Director from 1982 to 1992, Karo Healthcare AB, as Director, Pacira Biosciences, Inc., as Independent Director, Karo Bio USA, Inc., as Director, Meta Bio, as Director, DepoTech Corp., as President & Chief Operating Officer from 1998 to 1999, SkyePharma Plc, as President from 1999 to 2002, and Pacira Pharmaceuticals, Inc. (California), as President-US Operations.
Dr. Longenecker received his doctorate degree in 1980 from Australian National University and undergraduate degree in 1969 from Purdue University.
Posizioni attive di John P. Longenecker
| Società | Posizione | Inizio |
|---|---|---|
Jpl Biotech
 Jpl Biotech Miscellaneous Commercial ServicesCommercial Services Jpl Biotech provides consulting services to the biopharmaceutical industry. The private company is based in Cambridge. The American company was founded by John P. Longenecker. | Founder | - |
HBM Healthcare Investments (Cayman) Ltd.
 HBM Healthcare Investments (Cayman) Ltd. Hospital/Nursing ManagementHealth Services Part of HBM Partners AG, HBM Healthcare Investments (Cayman) Ltd. provides healthcare services. The private company is based in George Town, Cayman Islands. Andreas Wicki has been the CEO of the company since 2001. | Director/Board Member | - |
Precedenti posizioni note di John P. Longenecker
| Società | Posizione | Fine |
|---|---|---|
| AILERON THERAPEUTICS, INC. | Chief Executive Officer | 06/09/2018 |
HemaQuest Pharmaceuticals, Inc.
 HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | Chief Executive Officer | 01/05/2014 |
VitreoRetinal Technologies, Inc.
 VitreoRetinal Technologies, Inc. Medical SpecialtiesHealth Technology Vitreoretinal Technologies, Inc. was a pharmaceutical company. It was used to develop and commercialize innovative therapeutic systems for the treatment of serious ocular diseases. The company was founded in July 1999 and was headquartered in Irvine, CA. | President | 01/03/2010 |
| Favrille, Inc. | Chief Executive Officer | 01/01/2009 |
| SKYEPHARMA PLC | President | 01/02/2002 |
Formazione di John P. Longenecker
| Australian National University | Doctorate Degree |
| Purdue University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| AILERON THERAPEUTICS, INC. | Health Technology |
| KARO PHARMA AB (PUBL) | Health Technology |
| PACIRA BIOSCIENCES, INC. | Health Technology |
| Aziende private | 12 |
|---|---|
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
DepoTech Corp.
 DepoTech Corp. Medical SpecialtiesHealth Technology DepoTech, Inc. developed and manufactured sustained-release therapeutic products based on DepoFoam, an injectable drug-delivery technology. It's products are developed to treat major medical needs in fields such as cancer, infectious diseases, pain management and rheumatology. The company was headquartered in San Diego, CA. | Health Technology |
SkyePharma Plc
 SkyePharma Plc Pharmaceuticals: OtherHealth Technology SkyePharma Plc engaged in the provision of pharmaceutical business. It involved in development and supply of pharmaceutical products. The company was founded by Ian Roderick Gowrie-Smith on August 18, 1910 and was headquartered in London, the United Kingdom. | Health Technology |
| Favrille, Inc. | Health Technology |
VitreoRetinal Technologies, Inc.
VitreoRetinal Technologies, Inc. Medical SpecialtiesHealth Technology Vitreoretinal Technologies, Inc. was a pharmaceutical company. It was used to develop and commercialize innovative therapeutic systems for the treatment of serious ocular diseases. The company was founded in July 1999 and was headquartered in Irvine, CA. | Health Technology |
Karo Bio USA, Inc.
 Karo Bio USA, Inc. Miscellaneous Commercial ServicesCommercial Services Karo Bio USA, Inc. develops drug discovery technologies. It develops screening assays and drugs that work upon nuclear receptors. The company is headquartered in Chapel Hill, NC. | Commercial Services |
Pacira Pharmaceuticals, Inc. (California)
 Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Health Technology |
HemaQuest Pharmaceuticals, Inc.
HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | Health Technology |
MMRGlobal, Inc.
 MMRGlobal, Inc. Information Technology ServicesTechnology Services MMRGlobal, Inc. provides secure and web-based storage solutions. The company serves consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. Its product portfolio comprises of MyMedicalRecords, MyEsafeDepositBox, MMRPatientView and MMRPro. The company was founded in 2000 and is headquartered in Los Angeles, CA. | Technology Services |
| Meta Bio | |
HBM Healthcare Investments (Cayman) Ltd.
HBM Healthcare Investments (Cayman) Ltd. Hospital/Nursing ManagementHealth Services Part of HBM Partners AG, HBM Healthcare Investments (Cayman) Ltd. provides healthcare services. The private company is based in George Town, Cayman Islands. Andreas Wicki has been the CEO of the company since 2001. | Health Services |
Jpl Biotech
Jpl Biotech Miscellaneous Commercial ServicesCommercial Services Jpl Biotech provides consulting services to the biopharmaceutical industry. The private company is based in Cambridge. The American company was founded by John P. Longenecker. | Commercial Services |
- Borsa valori
- Insiders
- John P. Longenecker
